Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2012-09-06 21:02:44 UTC
Update Date2022-09-22 18:34:22 UTC
HMDB IDHMDB0028848
Secondary Accession Numbers
  • HMDB28848
Metabolite Identification
Common NameGlycyl-Phenylalanine
DescriptionGlycyl-Phenylalanine is a dipeptide composed of glycine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an 'Expected' metabolite.
Structure
Data?1582753347
Synonyms
ValueSource
Gly-pheMeSH
Gly-D-phenylalanineMeSH
Gly-L-phenylalanineMeSH
Glycyl-D-phenylalanineMeSH
Glycyl-L-phenylalanineMeSH
GlycylphenylalanineMeSH
Glycylphenylalanine monobrosylate, (L)-isomerMeSH
Glycylphenylalanine monohydrochloride, monohydrate, (L)-isomerMeSH
Glycylphenylalanine monotosylate, (L)-isomerMeSH
Glycylphenylalanine, (D)-isomerMeSH
Glycylphenylalanine, (L)-isomerMeSH
g-F DipeptideHMDB
GF DipeptideHMDB
Glycine phenylalanine dipeptideHMDB
Glycine-phenylalanine dipeptideHMDB
L-Glycyl-L-phenylalanineHMDB
2-[(2-Amino-1-hydroxyethylidene)amino]-3-phenylpropanoateGenerator, HMDB
Chemical FormulaC11H14N2O3
Average Molecular Weight222.2405
Monoisotopic Molecular Weight222.100442324
IUPAC Name2-[(2-amino-1-hydroxyethylidene)amino]-3-phenylpropanoic acid
Traditional Name2-[(2-amino-1-hydroxyethylidene)amino]-3-phenylpropanoic acid
CAS Registry NumberNot Available
SMILES
NCC(O)=NC(CC1=CC=CC=C1)C(O)=O
InChI Identifier
InChI=1S/C11H14N2O3/c12-7-10(14)13-9(11(15)16)6-8-4-2-1-3-5-8/h1-5,9H,6-7,12H2,(H,13,14)(H,15,16)
InChI KeyJBCLFWXMTIKCCB-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentDipeptides
Alternative Parents
Substituents
  • Alpha-dipeptide
  • Phenylalanine or derivatives
  • N-acyl-alpha amino acid or derivatives
  • N-acyl-alpha-amino acid
  • Alpha-amino acid amide
  • 3-phenylpropanoic-acid
  • Alpha-amino acid or derivatives
  • Amphetamine or derivatives
  • Monocyclic benzene moiety
  • Benzenoid
  • Amino acid or derivatives
  • Amino acid
  • Secondary carboxylic acid amide
  • Carboxamide group
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Organic nitrogen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Organooxygen compound
  • Primary amine
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Amine
  • Organic oxygen compound
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogP-2.29Extrapolated
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility1.21 g/LALOGPS
logP-2.1ALOGPS
logP-1.7ChemAxon
logS-2.5ALOGPS
pKa (Strongest Acidic)3.57ChemAxon
pKa (Strongest Basic)9.33ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area95.91 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity58.44 m³·mol⁻¹ChemAxon
Polarizability22.58 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+152.05331661259
DarkChem[M-H]-149.88331661259
DeepCCS[M+H]+144.09330932474
DeepCCS[M-H]-141.15230932474
DeepCCS[M-2H]-177.3530932474
DeepCCS[M+Na]+152.88930932474
AllCCS[M+H]+150.032859911
AllCCS[M+H-H2O]+146.232859911
AllCCS[M+NH4]+153.632859911
AllCCS[M+Na]+154.632859911
AllCCS[M-H]-150.332859911
AllCCS[M+Na-2H]-150.832859911
AllCCS[M+HCOO]-151.332859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.1.56 minutes32390414
Predicted by Siyang on May 30, 202210.0049 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20227.49 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid269.2 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Glycyl-PhenylalanineNCC(O)=NC(CC1=CC=CC=C1)C(O)=O3032.9Standard polar33892256
Glycyl-PhenylalanineNCC(O)=NC(CC1=CC=CC=C1)C(O)=O2002.5Standard non polar33892256
Glycyl-PhenylalanineNCC(O)=NC(CC1=CC=CC=C1)C(O)=O2158.1Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Glycyl-Phenylalanine,1TMS,isomer #1C[Si](C)(C)OC(CN)=NC(CC1=CC=CC=C1)C(=O)O2039.8Semi standard non polar33892256
Glycyl-Phenylalanine,1TMS,isomer #2C[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N=C(O)CN2058.6Semi standard non polar33892256
Glycyl-Phenylalanine,1TMS,isomer #3C[Si](C)(C)NCC(O)=NC(CC1=CC=CC=C1)C(=O)O2171.9Semi standard non polar33892256
Glycyl-Phenylalanine,2TMS,isomer #1C[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N=C(CN)O[Si](C)(C)C2047.6Semi standard non polar33892256
Glycyl-Phenylalanine,2TMS,isomer #2C[Si](C)(C)NCC(=NC(CC1=CC=CC=C1)C(=O)O)O[Si](C)(C)C2101.7Semi standard non polar33892256
Glycyl-Phenylalanine,2TMS,isomer #3C[Si](C)(C)NCC(O)=NC(CC1=CC=CC=C1)C(=O)O[Si](C)(C)C2145.0Semi standard non polar33892256
Glycyl-Phenylalanine,2TMS,isomer #4C[Si](C)(C)N(CC(O)=NC(CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C2266.8Semi standard non polar33892256
Glycyl-Phenylalanine,3TMS,isomer #1C[Si](C)(C)NCC(=NC(CC1=CC=CC=C1)C(=O)O[Si](C)(C)C)O[Si](C)(C)C2074.8Semi standard non polar33892256
Glycyl-Phenylalanine,3TMS,isomer #1C[Si](C)(C)NCC(=NC(CC1=CC=CC=C1)C(=O)O[Si](C)(C)C)O[Si](C)(C)C2118.8Standard non polar33892256
Glycyl-Phenylalanine,3TMS,isomer #2C[Si](C)(C)OC(CN([Si](C)(C)C)[Si](C)(C)C)=NC(CC1=CC=CC=C1)C(=O)O2255.5Semi standard non polar33892256
Glycyl-Phenylalanine,3TMS,isomer #2C[Si](C)(C)OC(CN([Si](C)(C)C)[Si](C)(C)C)=NC(CC1=CC=CC=C1)C(=O)O2252.9Standard non polar33892256
Glycyl-Phenylalanine,3TMS,isomer #3C[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N=C(O)CN([Si](C)(C)C)[Si](C)(C)C2266.3Semi standard non polar33892256
Glycyl-Phenylalanine,3TMS,isomer #3C[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N=C(O)CN([Si](C)(C)C)[Si](C)(C)C2231.0Standard non polar33892256
Glycyl-Phenylalanine,4TMS,isomer #1C[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N=C(CN([Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C2276.3Semi standard non polar33892256
Glycyl-Phenylalanine,4TMS,isomer #1C[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N=C(CN([Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C2247.6Standard non polar33892256
Glycyl-Phenylalanine,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(CN)=NC(CC1=CC=CC=C1)C(=O)O2269.7Semi standard non polar33892256
Glycyl-Phenylalanine,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N=C(O)CN2282.1Semi standard non polar33892256
Glycyl-Phenylalanine,1TBDMS,isomer #3CC(C)(C)[Si](C)(C)NCC(O)=NC(CC1=CC=CC=C1)C(=O)O2370.6Semi standard non polar33892256
Glycyl-Phenylalanine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N=C(CN)O[Si](C)(C)C(C)(C)C2472.4Semi standard non polar33892256
Glycyl-Phenylalanine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NCC(=NC(CC1=CC=CC=C1)C(=O)O)O[Si](C)(C)C(C)(C)C2521.4Semi standard non polar33892256
Glycyl-Phenylalanine,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)NCC(O)=NC(CC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C2534.6Semi standard non polar33892256
Glycyl-Phenylalanine,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)N(CC(O)=NC(CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C(C)(C)C2646.1Semi standard non polar33892256
Glycyl-Phenylalanine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)NCC(=NC(CC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C2686.2Semi standard non polar33892256
Glycyl-Phenylalanine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)NCC(=NC(CC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C2656.0Standard non polar33892256
Glycyl-Phenylalanine,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC(CC1=CC=CC=C1)C(=O)O2904.2Semi standard non polar33892256
Glycyl-Phenylalanine,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC(CC1=CC=CC=C1)C(=O)O2758.8Standard non polar33892256
Glycyl-Phenylalanine,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N=C(O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2859.1Semi standard non polar33892256
Glycyl-Phenylalanine,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N=C(O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2806.8Standard non polar33892256
Glycyl-Phenylalanine,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N=C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3089.1Semi standard non polar33892256
Glycyl-Phenylalanine,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N=C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C2933.4Standard non polar33892256
Spectra
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
  • Feces
  • Saliva
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedCancer patients undergoing total body irradiation details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)BothColorectal Cancer details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
UrineDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedCancer patients undergoing total body irradiation details
Associated Disorders and Diseases
Disease References
Colorectal cancer
  1. Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
  2. Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
  3. Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
Associated OMIM IDs
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB098201
KNApSAcK IDNot Available
Chemspider ID87926
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound97415
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Rai DK, Mooney A, Kenny PT: A tandem mass spectrometric investigation of N-(3-ferrocenyl-2-naphthoyl) dipeptide ethyl esters and N-(6-ferrocenyl-2-naphthoyl) dipeptide ethyl esters. Rapid Commun Mass Spectrom. 2011 Oct 15;25(19):2905-10. doi: 10.1002/rcm.5184. [PubMed:21913269 ]
  2. Pingitore F, Wesdemiotis C: Characterization of dipeptide isomers by tandem mass spectrometry of their mono- versus dilithiated complexes. Anal Chem. 2005 Mar 15;77(6):1796-806. [PubMed:15762588 ]
  3. Girelli AM, Mattei E, Messina A, Tarola AM: Inhibition of polyphenol oxidases activity by various dipeptides. J Agric Food Chem. 2004 May 19;52(10):2741-5. [PubMed:15137808 ]
  4. Thirumoorthy K, Soni K, Nandi N: The molecular recognition of dipeptide by oligoglycyl head group of amphiphile: a quantum chemical study. J Nanosci Nanotechnol. 2009 Jan;9(1):77-89. [PubMed:19441281 ]
  5. Turecek F, Syrstad EA, Seymour JL, Chen X, Yao C: Peptide cation-radicals. A computational study of the competition between peptide N-Calpha bond cleavage and loss of the side chain in the [GlyPhe-NH2 + 2H]+. cation-radical. J Mass Spectrom. 2003 Oct;38(10):1093-104. [PubMed:14595859 ]
  6. Anderson L, Bussler B, Martins H, Dufton M: Enkephalin-processing oligopeptidases in cobra venom: inhibition by thiorphan and bestatin reveals co-operative actions. Toxicon. 1998 May;36(5):719-28. [PubMed:9655632 ]
  7. Duman JG, Chen L, Palmer AE, Hille B: Contributions of intracellular compartments to calcium dynamics: implicating an acidic store. Traffic. 2006 Jul;7(7):859-72. [PubMed:16787398 ]
  8. Epand RM: Virus replication inhibitory peptide inhibits the conversion of phospholipid bilayers to the hexagonal phase. Biosci Rep. 1986 Jul;6(7):647-53. [PubMed:3779040 ]
  9. Lopez JJ, Camello-Almaraz C, Pariente JA, Salido GM, Rosado JA: Ca2+ accumulation into acidic organelles mediated by Ca2+- and vacuolar H+-ATPases in human platelets. Biochem J. 2005 Aug 15;390(Pt 1):243-52. [PubMed:15847604 ]
  10. Tobin MB, Cole SC, Miller JR, Baldwin JE, Sutherland JD: Amino-acid substitutions in the cleavage site of acyl-coenzyme A:isopenicillin N acyltransferase from Penicillium chrysogenum: effect on proenzyme cleavage and activity. Gene. 1995 Aug 30;162(1):29-35. [PubMed:7557412 ]